Cargando…

Correction to: BRAF Inhibitor Resistance in Meslanoma: Mechanisms and Alternative Therapeutic Strategies

Detalles Bibliográficos
Autores principales:	Zhong, Jingqin, Yan, Wangjun, Wang, Chunmeng, Liu, Wanlin, Lin, Xinyi, Zou, Zijian, Sun, Wei, Chen, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767990/ https://www.ncbi.nlm.nih.gov/pubmed/36459337 http://dx.doi.org/10.1007/s11864-022-01038-z

Ejemplares similares

BRAF Inhibitor Resistance in Melanoma: Mechanisms and Alternative Therapeutic Strategies
por: Zhong, Jingqin, et al.
Publicado: (2022)

Application of Multi-Omics Approach in Sarcomas: A Tool for Studying Mechanism, Biomarkers, and Therapeutic Targets
por: Zou, Zijian, et al.
Publicado: (2022)

Comparative analysis of adjuvant therapy for stage III BRAF‐mut melanoma: A real‐world retrospective study from single center in China
por: Zhong, Jingqin, et al.
Publicado: (2023)

Survival impact of immediate complete lymph node dissection for Chinese acral and cutaneous melanoma with micrometastasis in sentinel nodes: a retrospective study
por: Zhong, Jingqin, et al.
Publicado: (2023)

Correction: Cost-Effectiveness of Treatment Strategies for BRAF-Mutated Metastatic Melanoma
por: Curl, Patti, et al.
Publicado: (2015)

Potential Therapeutic Strategies to Overcome Acquired Resistance to BRAF or MEK Inhibitors in BRAF Mutant Cancers
por: Corcoran, Ryan B., et al.
Publicado: (2011)

Correction: BRAF inhibitor resistance of melanoma cells triggers increased susceptibility to natural killer cell-mediated lysis
Publicado: (2021)

Correction to: RIP1 protects melanoma cells from apoptosis induced by BRAF/MEK inhibitors
por: Lei, Fu Xi, et al.
Publicado: (2019)

Correction: An alternative to the black box: Strategy learning
por: Traub, Simon, et al.
Publicado: (2022)

Correction: Alternative strategies for mosquito-borne arbovirus control
por: Achee, Nicole L., et al.
Publicado: (2019)

Correction: A Novel SND1-BRAF Fusion Confers Resistance to c-Met Inhibitor PF-04217903 in GTL16 Cells though MAPK Activation
por: Lee, Nathan V., et al.
Publicado: (2012)

Correction: Automated Universal BRAF State Detection within the Activation Segment in Skin Metastases by Pyrosequencing-Based Assay U-BRAF(V600)
por: Skorokhod, Alexander, et al.
Publicado: (2013)

Correction: Proteomic Profile and In Silico Analysis in Metastatic Melanoma with and without BRAF Mutation
Publicado: (2015)

Correction: Autoinflammatory disease: clinical perspectives and therapeutic strategies
por: Kawakami, Atsushi, et al.
Publicado: (2022)

Correction: Unraveling the Evolution of the Atlantic Cod’s (Gadus morhua L.) Alternative Immune Strategy
por: Malmstrøm, Martin, et al.
Publicado: (2013)

Correction to: Alternative Treatment Strategies for Secondary Bacterial and Fungal Infections Associated with COVID-19
por: Das, Ritam, et al.
Publicado: (2022)

Correction to: Therapeutic strategy for acute appendicitis based on laparoscopic surgery
por: Shiihara, Masahiro, et al.
Publicado: (2023)

Correction: Alternating Antibiotics Render Resistant Bacteria Beatable
por: Richardson, Lauren A.
Publicado: (2015)

A real‐world study of adjuvant anti‐PD ‐1 immunotherapy on stage III melanoma with BRAF, NRAS, and KIT mutations
por: Sun, Wei, et al.
Publicado: (2023)

Correction to: Targeting hypoxia in tumor: a new promising therapeutic strategy
por: Bosco, Maria Carla, et al.
Publicado: (2020)

Publisher Correction: ‘TRAIL-based gene delivery and therapeutic strategies’ and ‘Overview of recent advances in liposomal nanoparticle-based cancer immunotherapy’
por: Zhong, Hui-ha, et al.
Publicado: (2020)

Correction: Modulation of Host Angiogenesis as a Microbial Survival Strategy and Therapeutic Target
por: Osherov, Nir, et al.
Publicado: (2016)

Correction to: Roles of tumor-associated macrophages in tumor progression: implications on therapeutic strategies
por: Zhu, Shuangli, et al.
Publicado: (2022)

Correction: AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma
por: Gu, Chunyan, et al.
Publicado: (2023)

Author Correction: Identification of recurrent USP48 and BRAF mutations in Cushing’s disease
por: Chen, Jianhua, et al.
Publicado: (2023)

Correction: A new GTF2I-BRAF fusion mediating MAPK pathway activation in pilocytic astrocytoma
por: Tomić, Tajana Tešan, et al.
Publicado: (2017)

Correction: Recent progress in ferroptosis: inducers and inhibitors
por: Du, Yunxi, et al.
Publicado: (2023)

Author Correction: Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors
por: Zhang, Peitao, et al.
Publicado: (2022)

BRAF inhibitor treatment of melanoma causing colonic polyps: An alternative hypothesis
por: Kelleher, Fergal C, et al.
Publicado: (2017)

Correction to: Therapeutic strategies for autism: targeting three levels of the central dogma of molecular biology
por: Hong, Derek, et al.
Publicado: (2023)

Correction: Sensitivity analysis of the CROPGRO-Canola model in China: A case study for rapeseed
por: Xu, Mancan, et al.
Publicado: (2023)

Correction to: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance
por: Zhang, Tao, et al.
Publicado: (2021)

Correction: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance
por: Zhang, Tao, et al.
Publicado: (2023)

Correction to: Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma
por: Doma, V., et al.
Publicado: (2019)

Correction to: Alternative NADH dehydrogenase extends lifespan and increases resistance to xenobiotics in Drosophila
por: Gospodaryov, Dmytro V., et al.
Publicado: (2020)

Author Correction: Disease-economy trade-offs under alternative epidemic control strategies
por: Ash, Thomas, et al.
Publicado: (2022)

Correction: Forgiver Triumphs in Alternating Prisoner's Dilemma
por: Zagorsky, Benjamin M., et al.
Publicado: (2014)

Correction: Replication Study: BET bromodomain inhibition as a therapeutic strategy to target c-Myc
por: Aird, Fraser, et al.
Publicado: (2018)

Correction: Use of extracellular vesicles from lymphatic drainage as surrogate markers of melanoma progression and BRAF(V600E) mutation
por: García-Silva, Susana, et al.
Publicado: (2019)

Correction: BRAF(V600E)-mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma
por: Chui, M. Herman, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hgm9fo4337131plc11fappd88m